Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ixabepilone in advanced renal cell carcinoma
NCT00182702Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jul 2005
- Primary completion
- Sep 2007
- Countries
- 1
01
Overview
A Phase 2 trial of ixabepilone in renal cell carcinoma (RCC), sponsored by National Cancer Institute. Started Jul 2005; status: completed.
02
Drugs
ixabepilone
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00182702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00182702.